Preeti Patel
VIDWAN ID: 449064

Dr Preeti Patel

Female Doctor of Philosophy
Associate Professor
Punjab
Expertise: Pharmacology and Pharmacy
175 Publications
1 Projects
2018 Scopus Citations
1750 CrossRef
14 Years 6 Months Total Experience
Publications
175 Total
Articles
156
Chapters
19
Activity

No publication activity to display.

Scopus Scopus
2,018 Citations
23 h-index
CrossRef CrossRef
1,750 Citations
22 h-index
Google Scholar Google Scholar

Loading Scholar statistics...

Professional Recognition

International Travel Grant from
2019
CSIR New Delhi
International Travel Grant from
2019
ICMR New Delhi
International Travel Grant from
2019
DST-SERB New Delhi
Best Oral Presentation
2014
Guru Ramdas Khalsa Institute of Science & Technology Pharmacy, Jabalpur, (M.P.).
GATE-2009 (Junior Research Fellowship
2009
Indian Institute of Technology (IIT), Roorkee
Junior/Senior Research Fellowship
2017
UGC New Delhi
Junior/Senior Research Fellowship
2014
DST-SERB New Delhi (PI-Dr. Harish Rajak)

Community & Membership

ISF college of Pharmacy
AQAR steering committee
Jan 2022
Association of Pharmaceutical Teachers of India
PU/LM-449-Life Time
Jan 2022
Madhya Pradesh State Pharmacy Council
Registered Pharmacist-21064-31/12/2024
Jan 2009

Personal Details

Doctor of Philosophy
2022
International Institute of Information Technology, Bangalore
Master of Pharmacy
2012
Hemwati Nandan Bahuguna Garhwal Univeristy, Srinagar, Garhwal
Bachelor of Pharmacy
2009
Hemwati Nandan Bahuguna Garhwal Univeristy, Srinagar, Garhwal
Associate Professor
Mar 2021 – Present
Unknown Organization
Research Fellow
Apr 2017 – Mar 2021
Guru Ghasidas Vishwavidyalaya, Bilaspur
Project Fellow
Dec 2014 – Mar 2017
Guru Ghasidas Vishwavidyalaya, Bilaspur
Assistant Professor
Mar 2012 – Nov 2014
Guru Ramdas Khalsa Institute of Science & Technology (Pharmacy), Kukrikheda, Barela, Jabalpur--483001
Medical and Health Sciences
Pharmacology and Pharmacy

Related Profiles

Scholarly Work

Design, synthesis and anticancer evaluation of 1,3,4-oxadiazole 2-thione analogues as HDAC and Thymidine Phosphorylase dual inhibitors
Other
Agency: Indian Council of Medical Research Role: Principal Investigator Grant: File No.: 5/13/20/2022/NCD-III

Drug Design...................... (Ongoing

University ISF College of Pharmacy
Year 2024
Downloads 0

Drug Design...................... (Ongoing

University ISF College of Pharmacy
Year 2024
Downloads 0

Drug Design...................... (Ongoing

University ISF College of Pharmacy
Year 2024
Downloads 0

Drug Design...................... (Ongoing

University ISF College of Pharmacy
Year 2024
Downloads 0

TRIAZOLO-THIAZOLE BASED HYDROXAMIC ACID ANALOGUES AS NOVEL ANTICANCER AGENT

Guru Ghasidas Vishwavidyalaya
- Application No. : 202021056509 Filed : 26-12-2022
Published : 01-07-2022 Published

Estrone based targeted liposomes as novel formulation for breast cancer therapy and method preparing thereof

Shivani Rai Paliwal
- Application No. : 202221046239 A Filed : 13-08-2022
Published : 26-08-2022 Published

Novel N-substituted (Z)-5-((E)-2-methyl-3-phenylallylidene-2-thioxothiazolidin-4-ones as inhibitors of aldoses reductase for the management of type-2 diabetes and associated complications

Sant Kumar Verma
ISF College of Pharmacy
- Application No. : 202211039622 A Filed : 11-07-2022
Published : 22-07-2022 Published

Synthesis of novel thiazolidinedione-acetamide conjugates as α-glycosidase inhibitors and uses there

Sant Kumar Verma
ISF College of Pharmacy
- Application No. : 202211033187 A Filed : 10-06-2022
Published : 17-06-2022 Published

A system for synthesizing novel analogues of nitrofurantoin based hydroxamic acids as anticancer agents

Harish Rajak
- Patent No. : 202022100777 Filed : 10-02-2022
Published : 03-03-2022 Granted

A process for synthesizing N-(6,12-dioxo-6,12-dihydroindolo[2,1-B]quinazoline-8-yl) benzenesulfonamide derivatives for anticancer activities

Guru Ghasidas Vishwavidyalaya
- Patent No. : 2021/10563 Filed : 26-12-2021
Published : 29-06-2022 Granted

Scholarly Publications

A Review on Thiadiazole Containing Compound as Potent Antineoplastic Agents

Book Chapter
Year: 2024. Pages: 101-108 .

Recent updates on c-Src kinase and Src-Abl nonreceptor tyrosine kinases inhibitors

Book Chapter
Year: 2024. Pages: 83-113 .
Authors: Navneesh; Shivanshu Pandey; Ruchi Shakya; Sumit Pasricha; Balak Das Kurmi; Preeti Patel

Inflammatory caspase-1, -4, and -5 and their role in anticancer activity

Book Chapter
Year: 2024. Pages: 33-54 .
Authors: Ruchi Shakya; Navneesh; Shivanshu Pandey; Sumit Pasricha; Balak Das Kurmi; Preeti Patel

Caspases activity assay procedures

Book Chapter
Year: 2024. Pages: 199-229 .
Authors: Sourabh Satapathy; Shivam Kumar; Vaibhav Nigam; Balak Das Kurmi; Ankur Vaidya; Akash Ved; Preeti Patel

Targeted Tumor Delivery

Book Chapter
Year: 2024. Pages: 309-337 .
Authors: Lakshmi Kumari; Lopamudra Mishra; Yash Sharma; Kanak Chahar; Satyam Khare; Balak Das Kurmi; Preeti Patel

Miscellaneous Targeting Approaches: Fundamentals of Gene Delivery and Overview of Colon, Liver, Macrophage, Mitochondrial, and M-Cell Targeting

Book Chapter
Year: 2024. Pages: 501-531 .
Authors: Akash Vikal; Rashmi Maurya; Avinash Dubey; Anjali Bisht; Abhinav Vashishat; Satyam Khare; Preeti Patel; Balak Das Kurmi

Role of block copolymers in ocular drug delivery

Book Chapter
Year: 2023. Pages: 327-354 .
Authors: Yash Sharma; Kanak Chahar; Mritunjay Kumar; Lopamudra Mishra; Lakshmi Kumari; Preeti Patel; Dilpreet Singh; Balak Das Kurmi

Solid Lipid Nanoparticles (SLNs): Advancements in Modification Strategies Toward Drug Delivery Vehicle

Review
Pharmaceutical Nanotechnology. Year: 2023. Volume: 11 , Issue: 2 , Pages: 138-154 .
Authors: Galal Mohsen Hussein Al-Sayadi; Abhishek Verma; Yash Choudhary; Pallavi Sandal; Preeti Patel; Dilpreet Singh; Ghanshyam Das Gupta; Balak Das Kurmi
Showing 1 to 8 of 175 publications